title: The host-encoded Heme Regulated Inhibitor (HRI) facilitates virulence-associated activities of bacterial pathogens.
abstract: Here we show that cells lacking the heme-regulated inhibitor (HRI) are highly resistant to infection by bacterial pathogens. By examining the infection process in wild-type and HRI null cells, we found that HRI is required for pathogens to execute their virulence-associated cellular activities. Specifically, unlike wild-type cells, HRI null cells infected with the gram-negative bacterial pathogen Yersinia are essentially impervious to the cytoskeleton-damaging effects of the Yop virulence factors. This effect is due to reduced functioning of the Yersinia type 3 secretion (T3S) system which injects virulence factors directly into the host cell cytosol. Reduced T3S activity is also observed in HRI null cells infected with the bacterial pathogen Chlamydia which results in a dramatic reduction in its intracellular proliferation. We go on to show that a HRI-mediated process plays a central role in the cellular infection cycle of the Gram-positive pathogen Listeria. For this pathogen, HRI is required for the post-invasion trafficking of the bacterium to the infected host cytosol. Thus by depriving Listeria of its intracellular niche, there is a highly reduced proliferation of Listeria in HRI null cells. We provide evidence that these infection-associated functions of HRI (an eIF2α kinase) are independent of its activity as a regulator of protein synthesis. This is the first report of a host factor whose absence interferes with the function of T3S secretion and cytosolic access by pathogens and makes HRI an excellent target for inhibitors due to its broad virulence-associated activities.
authors.affiliation: Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
authors.forename: Niraj
authors.initials: N
authors.lastname: Shrestha
authors.forename: Justin
authors.initials: J
authors.lastname: Boucher
authors.forename: Wael
authors.initials: W
authors.lastname: Bahnan
authors.forename: Emily S
authors.initials: ES
authors.lastname: Clark
authors.forename: Roland
authors.initials: R
authors.lastname: Rosqvist
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Fields
authors.forename: Wasif N
authors.initials: WN
authors.lastname: Khan
authors.forename: Kurt
authors.initials: K
authors.lastname: Schesser
mesh_terms: D000818:Animals; D001419:Bacteria / Q000472:pathogenicity*; D001424:Bacterial Infections / Q000235:genetics / Q000276:immunology; D002478:Cells, Cultured; D002692:Chlamydia trachomatis / Q000472:pathogenicity; D060467:Disease Resistance / Q000235:genetics; D005260:Female; D055785:Gene Knockdown Techniques; D006367:HeLa Cells; D054884:Host-Pathogen Interactions / Q000235:genetics; D006801:Humans; D008089:Listeria monocytogenes / Q000472:pathogenicity; D008297:Male; D051379:Mice; D037521:Virulence Factors / Q000502:physiology*; D015011:Yersinia pseudotuberculosis / Q000472:pathogenicity; D019892:eIF-2 Kinase / Q000502:physiology*
chemical_list: D037521:Virulence Factors; D019892:eIF-2 Kinase